Skip to main content

. 1966 Dec;41(220):684–687. doi: 10.1136/adc.41.220.684

Nephrotic syndrome in the course of treatment of Wilson's disease with DL-penicillamine.

M Karp, M Lurie, Z Yonis

PMCID: PMC2019685 PMID: 5927925

684

Images in this article

Fig. 1
on p.685

Fig. 2
on p.685

Fig. 3
on p.686

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

ADAMS D. A., GOLDMAN R., MAXWELL M. H., LATTA H. NEPHROTIC SYNDROME ASSOCIATED WITH PENICILLAMINE THERAPY OF WILSON'S DISEASE. Am J Med. 1964 Feb;36:330–336. doi: 10.1016/0002-9343(64)90096-8. [DOI] [PubMed] [Google Scholar]
GILSANZ V., BARRERA A., ANAYA A. The renal biopsy in Wilson's disease. Arch Intern Med. 1960 May;105:758–761. doi: 10.1001/archinte.1960.00270170096012. [DOI] [PubMed] [Google Scholar]
KARK R. M. Some aspects of nutrition and the kidney. Am J Med. 1958 Nov;25(5):698–707. doi: 10.1016/0002-9343(58)90007-x. [DOI] [PubMed] [Google Scholar]
PLAYOUST M. R., DALE N. E. Metabolic balance studies in a patient with Wilson's disease and hypercalcuria. Metabolism. 1961 Apr;10:304–314. [PubMed] [Google Scholar]
STERNLIEB I., SCHEINBERG I. H. PENICILLAMINE THERAPY FOR HEPATOLENTICULAR DEGENERATION. JAMA. 1964 Sep 7;189:748–754. doi: 10.1001/jama.1964.03070100042008. [DOI] [PubMed] [Google Scholar]
Vogel F. S. Nephrotoxic Properties of Copper under Experimental Conditions in Mice: With Special Reference to the Pathogenesis of the Renal Alterations in Wilson's Disease. Am J Pathol. 1960 Jun;36(6):699–711. [PMC free article] [PubMed] [Google Scholar]
WALSHE J. M. Wilson's disease; new oral therapy. Lancet. 1956 Jan 7;270(6906):25–26. doi: 10.1016/s0140-6736(56)91859-1. [DOI] [PubMed] [Google Scholar]
WOLFF S. M. Copper deposition in the rat. Arch Pathol. 1960 Feb;69:217–223. [PubMed] [Google Scholar]

ACTIONS

RESOURCES